Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome
- PMID: 27656431
- PMCID: PMC5028599
- DOI: 10.7860/JCDR/2016/20715.8347
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome
Abstract
Introduction: Acute Coronary Syndrome (ACS) is the leading cause of death worldwide. Oxidative stress and inflammation play important role in the destabilization of plaques leading to ACS. Markers which reflect this pathophysiologic mechanism may have prognostic value. Myeloperoxidase (MPO) and Sialic acid are markers of inflammation and oxidative stress. Both these markers are increased in patients with ACS. Their prognostic value in ACS is not well established.
Aim: To analyse the prognostic value of plasma myeloperoxidase and total sialic acid levels in patients with suspected acute coronary syndrome.
Materials and methods: A prospective study was conducted on 93 consecutively admitted patients with chest pain from July 2011 to September 2011. Plasma MPO and total sialic acid levels on admission were estimated spectrophotometrically. These were compared with extent of disease, development of complications during the hospital stay, left ventricular ejection fraction and mean duration of stay in hospital.
Results: Plasma MPO and total sialic acid levels were significantly higher in patients with myocardial infarction than those with unstable and stable angina (p<0.001 and p<0.007 respectively). The levels of plasma MPO and sialic acid levels were significantly higher in patients who developed complications like heart failure, arrhythmias, renal failure during their stay in hospital (p<0.011 and p<0.006 respectively). Ejection fraction was significantly low in patients with high MPO levels (p<0.011).
Conclusion: In patients with ACS, plasma MPO and total sialic acid levels on admission could predict the development of complications during their hospital stay. MPO levels correlated with ejection fraction in patients with ACS.
Keywords: Left ventricular ejection fraction; Major adverse cardiac event; Myocardial infarction.
Figures
![[Table/Fig-4]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5028599/326636235d70/jcdr-10-BC09-g001.gif)
![[Table/Fig-5]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5028599/153ad138294d/jcdr-10-BC09-g002.gif)
![[Table/Fig-7]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5028599/e68b77ef52b6/jcdr-10-BC09-g003.gif)
![[Table/Fig-8]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5028599/c6dfe514d00e/jcdr-10-BC09-g004.gif)
Similar articles
-
[Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Apr 24;46(4):284-291. doi: 10.3760/cma.j.issn.0253-3758.2018.04.007. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 29747324 Chinese.
-
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.Coron Artery Dis. 2010 May;21(3):129-36. doi: 10.1097/MCA.0b013e328333f50d. Coron Artery Dis. 2010. PMID: 20305551
-
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.Am J Cardiol. 2007 May 15;99(10):1364-8. doi: 10.1016/j.amjcard.2006.12.060. Epub 2007 Apr 5. Am J Cardiol. 2007. PMID: 17493461
-
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.J Am Coll Cardiol. 2007 May 22;49(20):1993-2000. doi: 10.1016/j.jacc.2007.02.040. Epub 2007 May 4. J Am Coll Cardiol. 2007. PMID: 17512353
-
Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.Ther Adv Cardiovasc Dis. 2015 Oct;9(5):275-84. doi: 10.1177/1753944715578405. Epub 2015 Mar 25. Ther Adv Cardiovasc Dis. 2015. PMID: 25814534
Cited by
-
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.Life (Basel). 2023 Sep 29;13(10):1992. doi: 10.3390/life13101992. Life (Basel). 2023. PMID: 37895374 Free PMC article. Review.
-
Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.Arq Bras Cardiol. 2019 Aug 29;113(4):667-674. doi: 10.5935/abc.20190159. eCollection 2019. Arq Bras Cardiol. 2019. PMID: 31482948 Free PMC article.
-
Neutrophil degranulation and myocardial infarction.Cell Commun Signal. 2022 Apr 11;20(1):50. doi: 10.1186/s12964-022-00824-4. Cell Commun Signal. 2022. PMID: 35410418 Free PMC article. Review.
-
Lipoprotein sialylation in atherosclerosis: Lessons from mice.Front Endocrinol (Lausanne). 2022 Sep 6;13:953165. doi: 10.3389/fendo.2022.953165. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157440 Free PMC article. Review.
References
-
- Cannon C. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation. 2002;106(13):1588–91. - PubMed
-
- Vitulli P, Tanzilli G, Marullo AGM, Peruzzi, M, Biondi Zoccai G. Inflammation and oxidative stress in acute coronary syndromes: a continuum from plaque vulnerability to thrombus formation. enliven. Clinical Cardiology and Research. 2014;1(3):005.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous